- Quanterix was founded in 2007 and has developed the Simoa technology, which uses single molecule counting for ultrasensitive protein biomarker detection in small sample volumes. - Simoa provides up to 1000x greater sensitivity than conventional immunoassays by analyzing samples in femtoliter-sized wells, allowing detection of single molecules. - The fully automated Simoa instrument provides quantitative results in under 75 minutes using small sample volumes with high precision and over a wide dynamic range.